Bortezomib
CAS 179324-69-7
Em Estoque
Bortezomib
Cat. No. ANT-BTZ-00CAS 179324-69-7Em Estoque
Dados Técnicos
Cat. No.ANT-BTZ-00
CAS179324-69-7
Fórmula Mol.C19H25BN4O4
Peso Mol.384.24 g/mol
IUPAC[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
SMILESB([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
InChIInChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1
Chave InChIGXJABQQUPOEUTA-RDJZCZTQSA-N
PurezaNA
Descrição
Visão geral
Boltezomib is an anti-cancer drug used to treat multiple myeloma and mantle cell lymphoma. This includes those who have not been treated before and multiple myeloma. It is commonly used in combination with other drugs. It is given by injection
A Anant Labs fabrica e fornece impurezas de Bortezomib de alta qualidade para o mercado global. Nossas impurezas EP de Bortezomib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acidBortezomib179324-69-7VelcadePS-341LDP-341NSC-681239LDP 341Bortezomib accord69G8BD63PP
